TNYA Tenaya Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$0.56
· of 52w range
· above low
· to high
$0.5352w low
$2.3552w high
Market Cap (MRQ)
$126M
P/E
-1.0
EPS
$-0.59
your badges
52W Range
$1–$2
Analyst Rating
BUY
Price Target
$3
P/E
-1.0
ROE
-81.2%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
TNYA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.56
Market Cap (MRQ)
$126M
P/E
-1.0
EPS
$-0.59
ROE
-81.2%
52W Range
$1–$2
TNYA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.592021-12-31 → 2025-12-31
Free Cash Flow$-69M2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | TNYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.05Y avg ≈-1.9 | ≈-1.9 | · | · | |
| P/B (MRQ) | 1.85Y avg ≈1.5 | ≈1.5 | 2.1 | Fair value | |
| Price / FCF (TTM) | -2.45Y avg ≈-3.2 | ≈-3.2 | · | · | |
| Price / Cash Flow (TTM) | -2.45Y avg ≈-4.0 | ≈-4.0 | · | · | |
| Price / Tangible Book | 1.05Y avg ≈1.5 | ≈1.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | TNYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -67.9%5Y avg ≈-54.6% | ≈-54.6% | -73.6% | In line | |
| ROE | -81.2%5Y avg ≈-70.4% | ≈-70.4% | -108.3% | Top tier | |
| ROIC | -75.7%5Y avg ≈-74.5% | ≈-74.5% | -75.7% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | TNYA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.55Y avg ≈7.1 | ≈7.1 | 4.8 | In line | |
| Quick Ratio | 6.55Y avg ≈6.8 | ≈6.8 | 3.7 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-23.9%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.20 | $-0.07 | -186.9% |
| March 31, 2026 | May 13, 2026 | $-0.09 | $-0.09 | -1.2% |
| Dec. 31, 2025 | $-0.12 | $-0.12 | 3.0% | |
| Sept. 30, 2025 | $-0.12 | $-0.15 | 20.4% | |
| June 30, 2025 | $-0.14 | $-0.26 | 45.1% | |
| March 31, 2025 | $-0.24 | $-0.19 | -23.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $69M | $87M | $98M | $95M | $54M | $31M | |
| SG&A Expense | $25M | $29M | $33M | $31M | $18M | $8M | |
| Operating Expenses | $93M | $116M | $131M | $126M | $73M | $39M | |
| Operating Income | $-93M | $-116M | $-131M | $-126M | $-73M | $-39M | |
| Interest Income | $3M | $5M | $7M | $2M | $108.0K | $87.0K | |
| Other Non-op | $52.0K | $82.0K | $53.0K | $2.0K | $-23.0K | $355.0K | |
| Pretax Income | $-91M | $-111M | $-124M | $-124M | $-73M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-91M | $-111M | $-124M | $-124M | $-73M | $-38M | |
| EPS (Basic) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · | |
| EPS (Diluted) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · | |
| Shares (Basic) | 152,971,259 | 84,822,468 | 73,786,126 | 44,823,597 | 17,734,166 | · | |
| Shares (Diluted) | 152,971,259 | 84,822,468 | 73,786,126 | 44,823,597 | 17,734,166 | · | |
| EBITDA | $-85M | $-107M | $-123M | $-119M | $-70M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $101M | $4M | $46M | $95M | $38M | $129M | |
| Short-term Investments | · | $57M | $59M | $91M | $213M | · | |
| Prepaid Expense | $5M | $6M | $7M | $7M | $4M | $1M | |
| Other Current Assets | $1M | $842.0K | $1M | $938.0K | · | · | |
| Current Assets | $106M | $67M | $112M | $194M | $255M | $130M | |
| PP&E (Net) | $28M | $36M | $43M | $51M | $43M | $17M | |
| PP&E (Gross) | $68M | $68M | $68M | $67M | $52M | $24M | |
| Accum. Depreciation | $40M | $32M | $24M | $16M | $9M | $7M | |
| Other Non-current Assets | $4M | $5M | $6M | $5M | $4M | $465.0K | |
| Total Assets | $147M | $120M | $171M | $279M | $314M | $148M | |
| Accounts Payable | $4M | $5M | $6M | $10M | $11M | $1M | |
| Accrued Liabilities | $9M | $8M | $13M | $11M | $9M | $3M | |
| Current Liabilities | $15M | $16M | $23M | $24M | $22M | $5M | |
| Capital Leases | $8M | $11M | $8M | $11M | $14M | · | |
| Other Non-current Liabilities | $410.0K | $281.0K | $253.0K | $228.0K | $182.0K | $19.0K | |
| Total Liabilities | $24M | $27M | $31M | $36M | $36M | $9M | |
| Common Stock | $21.0K | $8.0K | $7.0K | $7.0K | $4.0K | · | |
| Paid-in Capital | $728M | $607M | $543M | $523M | $434M | $2M | |
| Retained Earnings | $-605M | $-514M | $-403M | $-279M | $-156M | $-83M | |
| AOCI | $0 | $28.0K | $-106.0K | $-378.0K | $-141.0K | · | |
| Stockholders' Equity | $123M | $93M | $139M | $243M | $279M | $-81M | |
| Liabilities + Equity | $147M | $120M | $171M | $279M | $314M | $148M | |
| Shares Outstanding | 216,760,283 | 86,542,340 | 68,330,342 | 66,857,113 | 41,291,374 | 1,210,306 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $6M | $3M | $2M | |
| Stock-based Comp | $13M | $17M | $15M | $11M | $3M | $741.0K | |
| Other Non-cash | $851.0K | $-4M | $-2M | $1M | $6M | · | |
| Operating Cash Flow | $-68M | $-91M | $-102M | $-104M | $-61M | $-35M | |
| CapEx | $618.0K | $1M | $1M | $21M | $25M | $10M | |
| Investing Cash Flow | $56M | $1M | $49M | $84M | $-239M | $-7M | |
| Stock Issued | · | · | $4M | · | · | · | |
| Stock Repurchased | · | · | · | · | $13.0K | $1.0K | |
| Net Stock Activity | · | · | $4M | · | $-13.0K | · | |
| Financing Cash Flow | $108M | $48M | $4M | $78M | $209M | $147M | |
| Net Change in Cash | $96M | $-42M | $-49M | $57M | $-90M | $105M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-69M | $-92M | $-103M | $-125M | $-86M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.9% | -76.5% | -55.2% | -41.7% | -31.5% | · | |
| ROE | -81.2% | -108.2% | -81.5% | -56.2% | -25.0% | · | |
| ROIC | -75.7% | -124.9% | -94.1% | -51.6% | -26.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | 4.2 | 4.9 | 8.0 | 11.7 | · | |
| Quick Ratio | 6.5 | 3.8 | 4.6 | 7.7 | 11.5 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.57 | $1.07 | $2.04 | $3.64 | $6.75 | · | |
| Cash Flow / Share | $-0.45 | $-1.07 | $-1.38 | $-2.33 | · | · | |
| Cash / Share | $0.46 | $0.05 | $0.67 | $1.43 | $0.92 | · | |
| EPS (TTM) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-111M | $-124M | $-124M | $-73M | · | |
| Market Cap | $154M | $124M | $221M | $134M | $782M | · | |
| P/E | -1.2 | -1.1 | -1.9 | -0.7 | -4.6 | · | |
| P/B | 1.3 | 1.3 | 1.6 | 0.6 | 2.8 | · | |
| P / Tangible Book | 1.3 | 1.3 | 1.6 | 0.6 | 2.8 | · | |
| P / Cash Flow | -2.3 | -1.4 | -2.2 | -1.3 | -12.9 | · | |
| P / FCF | -2.2 | -1.4 | -2.1 | -1.1 | -9.1 | · | |
| Earnings Yield | -82.9% | -91.6% | -51.8% | -137.3% | -21.6% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $1M | $225.0K | · | · | $0 | $0 | |
| R&D Expense | $17M | $15M | $15M | $15M | $17M | $21M | |
| SG&A Expense | $5M | $5M | $6M | $6M | $7M | $6M | |
| Operating Expenses | $45M | $20M | $21M | $21M | $24M | $28M | |
| Operating Income | $-44M | $-20M | $-21M | $-21M | $-24M | $-28M | |
| Interest Income | $697.0K | $793.0K | $574.0K | $658.0K | $815.0K | $635.0K | |
| Other Non-op | $-2.0K | · | $26.0K | $3.0K | $-16.0K | $39.0K | |
| Pretax Income | $-43M | $-19M | $-20M | $-20M | $-23M | $-27M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-43M | $-19M | $-20M | $-20M | $-23M | $-27M | |
| EPS (Basic) | $-0.20 | $-0.09 | $-0.09 | $-0.12 | $-0.14 | $-0.24 | |
| EPS (Diluted) | $-0.20 | $-0.09 | $-0.09 | $-0.12 | $-0.14 | $-0.24 | |
| Shares (Basic) | 217,574,637 | 216,883,164 | · | 163,345,972 | 162,791,579 | 109,869,278 | |
| Shares (Diluted) | 217,574,637 | 216,883,164 | · | 163,345,972 | 162,791,579 | 109,869,278 | |
| EBITDA | $-44M | $-18M | · | $-21M | $-24M | $-25M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $81M | $101M | $56M | $63M | $54M | |
| Short-term Investments | · | · | · | · | $9M | $34M | |
| Receivables | $371.0K | $11M | · | · | · | · | |
| Prepaid Expense | $8M | $5M | $5M | $5M | $4M | $6M | |
| Other Current Assets | $4M | $25.0K | $1M | $990.0K | $218.0K | $1M | |
| Current Assets | $86M | $97M | $106M | $61M | $76M | $94M | |
| PP&E (Net) | $2M | $26M | $28M | $29M | $31M | $33M | |
| PP&E (Gross) | $27M | $68M | $68M | $68M | $68M | $68M | |
| Accum. Depreciation | $25M | $42M | $40M | $39M | $37M | $35M | |
| Other Non-current Assets | $2M | $4M | $4M | $4M | $4M | $5M | |
| Total Assets | $94M | $135M | $147M | $105M | $122M | $144M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $5M | |
| Accrued Liabilities | $8M | $6M | $9M | $7M | $7M | $6M | |
| Current Liabilities | $19M | $17M | $15M | $13M | $13M | $14M | |
| Capital Leases | $1M | $7M | $8M | $9M | $9M | $10M | |
| Other Non-current Liabilities | $103.0K | $418.0K | $410.0K | $301.0K | $293.0K | $287.0K | |
| Total Liabilities | $24M | $29M | $24M | $22M | $22M | $25M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $16.0K | $16.0K | $16.0K | |
| Paid-in Capital | $737M | $730M | $728M | $668M | $664M | $661M | |
| Retained Earnings | $-668M | $-624M | $-605M | $-585M | $-565M | $-541M | |
| AOCI | · | · | $0 | · | $-1.0K | $-10.0K | |
| Stockholders' Equity | $69M | $106M | $123M | $83M | $100M | $119M | |
| Liabilities + Equity | $94M | $135M | $147M | $105M | $122M | $144M | |
| Shares Outstanding | 224,230,012 | 216,998,876 | 216,760,283 | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $2M | $2M | $3M | $3M | $4M | $4M | |
| Other Non-cash | · | $-4M | · | · | · | $-3M | |
| Operating Cash Flow | $-4M | $-19M | $-14M | $-16M | $-16M | $-23M | |
| CapEx | $159.0K | $11.0K | $67.0K | $26.0K | $142.0K | $383.0K | |
| Investing Cash Flow | $-159.0K | $-11.0K | $-67.0K | $9M | $25M | $22M | |
| Financing Cash Flow | $909.0K | $-415.0K | $58M | $380.0K | $-476.0K | $50M | |
| Net Change in Cash | $-3M | $-20M | $44M | $-6M | $9M | $49M | |
| Free Cash Flow | · | $-19M | · | · | · | $-23M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3971.9% | -8917.8% | · | · | · | · | |
| Net Margin | -3909.3% | -8565.3% | · | · | · | · | |
| Pretax Margin | -3909.3% | -8565.3% | · | · | · | · | |
| EBITDA Margin | -3971.9% | -8134.2% | · | · | · | · | |
| ROA | -40.2% | -13.8% | · | -16.5% | -16.3% | -16.3% | |
| ROE | -51.3% | -17.1% | · | -20.7% | -19.9% | -19.4% | |
| ROIC | -63.5% | -18.9% | · | · | · | -23.1% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 5.8 | · | 4.6 | 6.0 | 6.7 | |
| Quick Ratio | 4.1 | 5.5 | · | 4.3 | 5.7 | 6.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 6.0 | 0.0 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.31 | $0.49 | · | · | · | · | |
| Revenue / Share | $0.01 | $0.00 | · | · | · | · | |
| Cash Flow / Share | · | $-0.09 | · | · | · | $-0.21 | |
| Cash / Share | $0.35 | $0.37 | · | · | · | · | |
| EPS (TTM) | $-0.50 | $-0.44 | · | $-0.77 | $-0.95 | $-1.15 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-103M | $-83M | · | $-94M | $-100M | $-106M | |
| Market Cap | $166M | $150M | · | · | · | · | |
| P/E | -1.5 | -1.6 | · | -2.1 | -0.6 | -0.5 | |
| P/B | 2.4 | 1.4 | · | · | · | · | |
| P / Tangible Book | 2.4 | 1.4 | · | · | · | · | |
| P / Cash Flow | · | -7.8 | · | · | · | · | |
| Earnings Yield | -67.7% | -63.6% | · | -47.5% | -155.5% | -201.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-91M | $-111M | $-124M | $-124M | $-73M |
| Diluted EPS | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 6.8 | 4.2 | 4.9 | 8.0 | 11.7 |
| Quick Ratio | 6.5 | 3.8 | 4.6 | 7.7 | 11.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-69M | $-92M | $-103M | $-125M | $-86M |
Institutional owners (13F) 113 filers · $44.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
113
Value held
$44.3M
New positions
20
Exited positions
19
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 20 (-7 vs prior Q) | 19 (+3 vs prior Q) | 33 (-2 vs prior Q) | 18 (-1 vs prior Q) | -858K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6,094,797 | 8,560,108 | 13.77% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $5,247,833 | 7,101,263 | 11.86% | Shares |
| MILLENNIUM MANAGEMENT LLC | $4,752,153 | 6,429,648 | 10.74% | Shares |
| CITADEL ADVISORS LLC | $3,375,303 | 4,566,774 | 7.63% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $3,164,161 | 4,281,100 | 7.15% | Shares |
| BlackRock, Inc. | $2,962,845 | 4,008,719 | 6.69% | Shares |
| Empery Asset Management, LP | $2,855,228 | 3,863,115 | 6.45% | Shares |
| MARSHALL WACE, LLP | $2,592,352 | 3,503,178 | 5.86% | Shares |
| Burkehill Global Management, LP | $1,478,200 | 2,000,000 | 3.34% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,356,805 | 1,834,674 | 3.07% | Shares |
| ADAR1 Capital Management, LLC | $1,149,670 | 1,555,500 | 2.60% | Shares |
| Raiffeisen Bank International AG | $881,880 | 1,200,000 | 1.99% | Shares |
| Euclidean Capital LLC | $750,708 | 1,015,705 | 1.70% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $729,766 | 987,505 | 1.65% | Shares |
| Mirador Capital Partners LP | $668,957 | 905,097 | 1.51% | Shares |
| STATE STREET CORP | $523,816 | 708,721 | 1.18% | Shares |
| Squarepoint Ops LLC | $487,249 | 659,247 | 1.10% | Shares |
| UBS Group AG | $337,394 | 456,555 | 0.76% | Shares |
| JANE STREET GROUP, LLC | $332,917 | 450,435 | 0.75% | Shares |
| StepStone Group LP | $318,892 | 462,163 | 0.72% | Shares |
| TWO SIGMA INVESTMENTS, LP | $281,442 | 380,790 | 0.64% | Shares |
| TWO SIGMA ADVISERS, LP | $280,687 | 394,500 | 0.63% | Shares |
| Casdin Capital, LLC | $267,531 | 361,969 | 0.60% | Shares |
| Invesco Ltd. | $262,279 | 354,862 | 0.59% | Shares |
| NORTHERN TRUST CORP | $256,003 | 346,371 | 0.58% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $240,441 | 325,316 | 0.54% | Shares |
| XTX Topco Ltd | $231,699 | 313,488 | 0.52% | Shares |
| DAFNA Capital Management LLC | $221,730 | 300,000 | 0.50% | Shares |
| GOLDMAN SACHS GROUP INC | $217,841 | 294,739 | 0.49% | Shares |
| Marex Group Ltd | $174,058 | 235,500 | 0.39% | Shares |
| MORGAN STANLEY | $171,688 | 232,293 | 0.39% | Shares |
| CITADEL ADVISORS LLC | $148,485 | 200,900 | 0.34% | Call option |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $143,977 | 194,800 | 0.33% | Shares |
| Almanack Investment Partners, LLC. | $124,317 | 168,200 | 0.28% | Shares |
| CITIGROUP INC | $68,305 | 92,417 | 0.15% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $66,310 | 76,183 | 0.15% | Shares |
| Pathstone Holdings, LLC | $55,433 | 75,000 | 0.13% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $54,020 | 73,000 | 0.12% | Call option |
| DIMENSIONAL FUND ADVISORS LP | $47,971 | 64,904 | 0.11% | Shares |
| Cetera Investment Advisers | $42,221 | 57,125 | 0.10% | Shares |
| Vanguard Global Advisers, LLC | $37,002 | 50,070 | 0.08% | Shares |
| Callan Family Office, LLC | $37,000 | 50,061 | 0.08% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32,782 | 44,300 | 0.07% | Put option |
| JANE STREET GROUP, LLC | $31,633 | 42,800 | 0.07% | Call option |
| Point72 Asia (Singapore) Pte. Ltd. | $28,447 | 17,560 | 0.06% | Shares |
| Spark Investment Management LLC | $26,238 | 35,500 | 0.06% | Shares |
| Vanguard Personalized Indexing Management, LLC | $25,773 | 34,871 | 0.06% | Shares |
| OSAIC HOLDINGS, INC. | $25,576 | 34,563 | 0.06% | Shares |
| China Universal Asset Management Co., Ltd. | $25,525 | 34,535 | 0.06% | Shares |
| H D Vest Advisory Services | $23,531 | 38,500 | 0.05% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| The Column Group III, LP, The Column Group III-A, LP, The Column Group III GP, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson ×8 filings | Feb. 26, 2026 | 23.10% | Amendment | · | SEC |
| Casdin Capital, LLC, Casdin Partners Master Fund, L.P., Casdin Partners GP, LLC, Eli Casdin ×4 filings | March 7, 2025 | 4.30% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 18 insiders · 7 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Faraz Ali | Chief Executive Officer | Sept. 10, 2026 A | 539,782 | 0 | 9 | $-32,132 |
| Eric J Hyllengren | Chief Financial Officer | July 13, 2026 A | · | 0 | 0 | $0 |
| Whittemore Tingley | Chief Medical Officer | Sept. 10, 2026 A | 263,073 | 0 | 9 | $-14,865 |
| Tomohiro Higa | SVP, Finance | May 18, 2026 S | 118,267 | 0 | 5 | $-5,211 |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | Nov. 18, 2024 S | 60,983 | 0 | 0 | $0 |
| Timothy Hoey | Chief Scientific Officer | March 5, 2024 S | 245,346 | 0 | 0 | $0 |
| Leone D Patterson | Chief Fin. and Bus. Officer | Feb. 23, 2024 A | 95,755 | 0 | 0 | $0 |
| Amy L. Burroughs | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Deepak Srivastava | Director | May 28, 2026 A | 372,435 | 0 | 0 | $0 |
| Catherine Stehman-Breen | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| June Lee | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Karah Herdman Parschauer | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Jeffrey T. Walsh | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Sanders R Williams | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| David V Goeddel | Director | May 29, 2025 A | 49,313,559 | 0 | 0 | $0 |
| Jin-Long Chen | Director | June 9, 2023 A | · | 0 | 0 | $0 |
| Eli Casdin | Director | June 10, 2022 A | 361,969 | 0 | 0 | $0 |
| Jeenjoo Kang | Director | Aug. 3, 2021 C | 25,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 6 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.45% | 174,387 SH | Oct. 1, 2026 | Daily |
| IBB · iShares Trust | 0.01% | 1,588,805 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.01% | 15,116 SH | Oct. 1, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 222,417 SH | Oct. 1, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,768,551 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 5,136,220 SH | Aug. 19, 2026 | Daily |
TNYA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$3.00
+431.8%
4 30.8%
Strong Buy
8 61.5%
Buy
1 7.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-28Mean target $3.20 +467.3%
← Below all targets
Current price $0.56
Low$2.00
Mean$3.20
High$5.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| VTVT | · | · | · | · | -70.4% | · |
| HURA | · | -1.2 | · | · | · | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026